Vemurafenib and ipilimumab plus dacarbazine extend survival in metastatic melanomaJANE SALODOF MACNEIL; MARY JO M. DALES · 2011

Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanomaYamazaki, N.; Uhara, H.; Fukushima, S.; Uchi, H.; Shibagaki, N.; Kiyohara, Y.; Tsutsumida, A.; Namikawa, K.; Okuyama, R.; Otsuka, Y.; Tokudome, T. · Cancer Chemotherapy and Pharmacology · 2015

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III TrialMaio, M.; Grob, J.-J.; Aamdal, S.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Chiarion-Sileni, V.; Testori, A.; Chen, T.-T.; Tschaika, M.; Wolchok, J. D. · Journal of Clinical Oncology · 2015

9318 POSTER Phase 3 Randomized Study of Ipilimumab (IPI) Plus Dacarbazine (DTIC) Vs DTIC Alone as First Line Treatment in Patients With Unresectable Stage III or IV MelanomaRobert, C.; Thomas, L.; Garbe, C.; Lebbe, C.; Baurain, J.F.; Testori, A.; Maio, M.; Chen, T.; Hoos, A.; Wolchok, J. · European Journal of Cancer · 2011

HydroceleThe New England Journal of Medicine, Surgery and Collateral Branches of Science · 1812

Diabetes MellitusThe New England Journal of Medicine, Surgery and Collateral Branches of Science · 1812

Notice of the LateLLOYD, JAMES · The New England Journal of Medicine, Surgery and Collateral Branches of Science · 1813

Massachusetts Medical SocietyThe New England Journal of Medicine, Surgery and Collateral Branches of Science · 1813

The Death of Dr. WarrenThe New England Journal of Medicine, Surgery and Collateral Branches of Science · 1815

Death of Dr. BowenThe New England Journal of Medicine, Surgery and Collateral Branches of Science · 1815

ObituaryThe New England Journal of Medicine, Surgery and Collateral Branches of Science · 1816

Death of John Ferriar, M.D.The New England Journal of Medicine, Surgery and Collateral Branches of Science · 1816